A systematic review showed that high levels of IGF-1 and IGFBP-3 were positively correlated with premenopausal breast cancer risk38, while IGFBP-3 was found to have a protective effect in our study, which might be due to the bidirectional carcinogenic mechanism of IGFBP-3. Here, IGFBP3 is linked to breast cancer.